September 17, 2014

Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

pin it button Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

vaccine boy 225x300 Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

by Michael Belkin
TheRefusers.com

This is a legal filing by former Merck virologists who claim they were pressured by Merck management to participate in fraud by falsifying Merck’s mumps vaccine efficacy rate in clinical trials. This filing claims that the mumps vaccine efficacy rate is significantly lower than the 95% that Merck has misrepresented to the government and the public. The mumps vaccine is a component of MMR.

The most disturbing thing about this allegation by company insiders is that Merck would deliberately (not accidentally) enforce a policy of lying about vaccine effectiveness. If they would lie about vaccine efficacy, do you suppose Merck would be truthful about vaccine adverse reactions and safety? Or would they use the same management policy of pressuring company scientists and employees to sugar-coat vaccine safety data?

Keep in mind that Roche (another major drug company) is under investigation by the European Medicines Agency for ignoring 80,000 adverse reactions, including 15,161 deaths. See the pattern? Lie about product efficacy and then ignore adverse reactions. That is business as usual in the pharmaceutical industry. Why do consumers trust their products?

Filed April 27, 2012

UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

United States of America ex rel.,
Stephen A Krahling and Joan A
Wlochowski,

Plaintiffs,

v,

Merck & Co., Inc.
Defendant

Civil action No. 10-4374 (CDJ)

AMENDED COMPLAINT
VIOLATIONS OF THE FEDERAL FALSE CLAIMS ACT

JURY TRIAL DEMANDED

Stephen Krahling and Joan Wlochowski bring this action as Relators on behalf of the United States against their former employer, Merck & Co., Inc. (“Merck”), under the False Claims Act and allege — upon knowledge with respect to their own acts and those they personally witnessed and upon information and belief with respect to all other matters – as follows:

Introduction

1. This case is about Merck’s efforts for more than a decade to defraud the United States through Merck’s ongoing scheme to sell the government a mumps vaccine that is mislabeled, misbranded, adulterated and falsely certified as having an efficacy rate that is significantly higher than it actually is.

2. Specifically, in an effort to maintain its exclusive license to sell the vaccine and its monopoly of the U.S. market for mumps vaccine, Merck has fraudulently represented and continues to falsely represent in its labeling and elsewhere that its mumps vaccine has an efficacy rate of 95 percent or higher. This is the efficacy rate on which Merck’s original government approval for the vaccine was based more than forty years ago, In truth, Merck knows and has taken affirmative steps to conceal – such as by using improper testing techniques, falsifying test data in a clinical trial, and violating multiple duties of government disclosure – that the efficacy rate of Merck’s mumps vaccine is, and has been since at least 1999. significantly lower than this 95 percent rate.

3. Relators Krahling and Wlochowski were employed as virologists in the Merck lab that performed this fraudulent efficacy testing. They witnessed firsthand the improper testing and data falsification in which Merck engaged to conceal what Merck knew about the vaccine’s diminished efficacy. In fact, their Merck superiors and senior management pressured them to participate in the fraud and subsequent coverup when Relators objected to and tried to stop it.

4. As, a result of Merck’s fraudulent scheme, the United States has over the last decade paid Merck hundreds of millions of dollars for a vaccine that does not provide the efficacy Merck claims it provides and does not provide the public with adequate immunization. Had Merck complied with its multiple duties of disclosure and reported what it knew of the vaccine’s diminished efficacy – rather than engage in fraud and concealment — that information would have affected (or surely had the potential to affect, which is all the law requires) the government’s decision to purchase the vaccine. However, since the government was not fully informed, it did not have the opportunity to consider its options, including not purchasing the vaccine from Merck, paying less, requiring a labeling change, requiring additional testing, or prioritizing development and approval of a new vaccine from Merck or another manufacturer.

5, Merck’s failure to disclose what it knew about the diminished efficacy of its mumps vaccine has caused the government to purchase mislabeled, misbranded, adulterated and falsely certified vaccines in violation of Merck’s contract with the Centers for Disease Control(“CDC’”) and in violation of the law.

6. As the single largest purchaser of childhood vaccines {accounting for more than 50 percent of all vaccine purchases}, the United States is by far the largest financial victim of Merck’s fraud. But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps. And while this is a disease the CDC targeted to eradicate by now, the failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.

7. Relators bring this case on behalf of the United States to recover the funds that the government spent for this fraudulently mislabeled, misbranded, adulterated and falsely certified vaccine, and for all associated penalties. They also bring this case to stop Merck from continuing with its scheme to misrepresent the true efficacy of its mumps vaccine and require Merck to comply with its reporting, labeling and testing obligations under its contract with the CDC and under this country’s vaccine regulatory regime.

PARTIES

8. Relator Stephen A. Krahling is a citizen of the United States and a resident of Pennsylvania. He was employed by Merck from 1999 to 2001 as a virologist in Merck’s vaccine division located in West Point, Pennsylvania. During his employment at Merck, Krahling witnessed firsthand, and was asked to directly participate in, fraud in a clinical trial relating to the efficacy of Merck’s mumps vaccine.

9, Relator Joan Wlochowski is a citizen of the United States and a resident of Connecticut. She was employed by Merck from January 2001 to August 2002 as a virologist in Merck’s vaccine division in West Point, Pennsylvania. During her employment there, Wlochowski also witnessed firsthand, and was asked to directly participate in, fraud in a clinical trial relating to the efficacy of Merck’s mumps vaccine.

10, Defendant Merck is headquartered in New Jersey with its vaccine division based in West Point, Pennsylvania. Merck is one of the largest pharmaceutical companies in the world with annual revenues exceeding $20 billion. Merck is also a leading seller of childhood vaccines and currently markets in the U.S. vaccines for 12 of the 17 diseases for which the CDC currently recommends vaccination.

11. Merck is the sole manufacturer licensed by the Food and Drug Administration (“FDA”) to sell mumps vaccine in the United States, Merck’s mumps vaccine, together with Merck’s vaccines against measles and rubella are sold as MMRII Merck annually sells more than 7.6 million doses of the vaccine in the U.S. for which it derives hundreds of millions of dollars of revenue. The US purchases approximately 4 million of these doses annually, Merck also has a license in the U.S. to sell ProQuad, a quadravalent vaccine containing MMRII vaccine and chickenpox vaccine. Under a license from the European Medicines Agency (“EMA”), Merck also sells mumps vaccine in Europe as a part of the trivalent MMRVaxpro and the quadrivalent ProQuad through Sanofi Pasteur MSD, a joint venture with the vaccine division of the Sanofi Aventis Group. ProQuad has been sold intermittently in the U.S. and Europe from its approval in 2005 until 2010.

Read the original document

Comment on this story here: http://therefusers.com/refusers-newsroom/merck-is-sued-by-former-virologist-employees-for-deliberately-falsifying-mumps-vaccine-efficacy-studies/

Vaccine Epidemic
How Corporate Greed, Biased Science, and Coercive Government Threaten Our Human Rights, Our Health, and Our Children
by Louise Kuo Habakus and Mary Holland J.D.

Vaccine Epidemic bookcover Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

FREE Shipping Available!
More Info

 

0 commentsback to post

Other articlesgo to homepage

CDC Whistleblower Dr. Thompson: “I’ve Stopped Lying” – Willing to Testify on Vaccine Fraud

CDC Whistleblower Dr. Thompson: “I’ve Stopped Lying” – Willing to Testify on Vaccine Fraud

Pin It

The Autism Media Channel has released another video from CDC Whistleblower Dr. William Thompson, confessing to the fact that he was asked by his boss to lie, and that he’s now “stopped lying.”

In the video, Thompson states that the CDC has “become paralyzed” over the vaccine-autism issue. He states that the whole branch of the vaccine division is “becoming more paralyzed, with less and less being done.”

This failure by the CDC to investigate why vaccines cause autism in some children has “put the research 10 years behind” according to Thompson. He states that “because the CDC has not been transparent, we missed 10 years of research.”

Thompson goes on to state that we need Congress to come in and look at all the data related to vaccines and autism that has been previously withheld by the CDC, and have an independent contractor look at it. Thompson makes it clear that he is ready to testify before Congress, if asked to do so.

How the Government has Earned $3.5 BILLION from the Claim that Vaccines Don’t Cause Autism

How the Government has Earned $3.5 BILLION from the Claim that Vaccines Don’t Cause Autism

Pin It

Few among the American public truly understand just how huge the U.S. vaccine market is. Not only do drug companies reap huge profits from vaccines, so too does the U.S. government.

For example, did you know that the U.S. Department of Health and Human Services has accumulated $3.5 BILLION in vaccine tax revenue which is currently “sitting” in the Vaccine Injury Compensation Trust Fund?

This trust fund was established in 1988 “to compensate vaccine-related injury or death claims for covered vaccines.” The money in this fund comes from a $0.75 excise tax on vaccines recommended by the CDC.

So why does this Trust Fund have such a high balance, instead of paying medical expenses to families with vaccine damaged children? Probably because the government has decided that vaccines do not cause autism, the most common claim filed in the National Vaccine Injury Compensation Program since its inception in 1986.

Boy Held by Chicago Hospital in Medical Kidnapping Case Returns Home

Boy Held by Chicago Hospital in Medical Kidnapping Case Returns Home

Pin It

Local Fox News affiliate Fox4kc in Kansas City has reported that 17-year-old Isaiah Rider has returned home to Kansas City, even though the State of Illinois still retains his custody rights. Isaiah was released from Luries Children’s Hospital in Chicago where he was being held against his will, and the will of his family. He is reportedly staying with grandparents while his mother fights back against “medical abuse” charges for disagreeing with the hospital’s treatment and wanting to transfer him to a different hospital. Isaiah lost 5 months of his life to confinement in a hospital, and is now anxious to get back to school and resume his life.

Isaiah’s mother Michelle believes they held her son to conduct medical experimentation on his rare disease, Neurofibromatosis. Michelle will return to Chicago Friday to face trial. But in the meantime, at least Isaiah is back home in Kansas City, staying with his grandparents.

Dr. Oz Warns About Mercury in Flu Shots

Dr. Oz Warns About Mercury in Flu Shots

Pin It

Dr. Oz spent considerable time covering the issue of thimerosal being used as a preservative in the annual flu vaccine. Thimerosal contains mercury, a well-known neuro-toxin. Dr. Oz interviewed Dr. Mark Hyman and former U.S. Senator and Attorney General Robert F. Kennedy, Jr. on his show to discuss mercury in vaccines.

While it is certainly worthwhile to warn the public of the dangers of mercury in the flu vaccine, Marcella Piper-Terry of VaxTruth.org points out several facts regarding this issue that were not covered during the show, and how Dr. Oz did not exactly get his facts straight on a few things.

Sadly, this is representative of the current level of knowledge concerning vaccines both among the mainstream media and modern-day physicians. Parents of vaccine-damaged children do their homework and research well, and in many cases are more educated on this issue than both the mass media and many doctors.

CDC’s Purchase of $4 Billion of Vaccines a Conflict of Interest in Overseeing Vaccine Safety

CDC’s Purchase of $4 Billion of Vaccines a Conflict of Interest in Overseeing Vaccine Safety

Pin It

Do you trust the U.S. Centers for Disease Control (CDC) to oversee vaccine safety, when they have an annual budget of over $4 billion to purchase vaccines from drug companies? In 2015, they want to increase that amount by another half a billion dollars.

Dr. Brian Hooker says the CDC should not be trusted to oversee vaccine safety, and after 10 years of fighting legal battles with the CDC via Freedom of Information requests to secure raw data on vaccine safety studies, he now has solid evidence to back up his claim of fraud within the CDC.

In a shocking news story that rocked the online world but was almost totally ignored by the mainstream media a couple of weeks ago, senior vaccine scientist Dr. William Thompson was revealed as a whistleblower within the CDC, admitting that the CDC had withheld information from a key study in 2004 that supposedly showed that the MMR childhood vaccine was safe.

The CDC was forced to issue a response, and Dr. Hooker has now shown that the CDC response is clearly trying to cover up ethical lapses and explain away key data that was omitted from their original study. This data which was hidden from the public for more than 10 years was not favorable towards their own bias and what they wanted the public to believe about vaccines and autism. Dr. Hooker has clearly shown that the CDC has a conflict of interest, and cannot be trusted with research on vaccine safety when it is spending more than $4 billion of taxpayer funds to purchase vaccines from drug manufacturers.

So what’s next? Will this fraud within the CDC be allowed to continue? There are reports that there are other whistleblowers within the CDC that would like to come forward, but are too fearful at this point. Dr. William Thompson is now represented by one of the top whistleblower attorneys in the nation, and has reportedly turned over more than 1000 documents to Congressman Bill Posey.

The pharmaceutical industry is the richest and most powerful political lobby in the world, however. Will there be enough members of Congress to come forward and oppose them? Does the American public even care enough about this issue to take action and threaten lawmakers who refuse to act and remove vaccine safety oversight from the CDC? Will they demand that taxpayer funds NOT be increased by over a half billion dollars next year to fund the purchase of more vaccines that are produced by pharmaceutical companies who are convicted criminals, and whose products have not been proven safe? More:

read more


Get the news right in your inbox!